ASCO 2026: Why Experts Say Galleri Multi-Cancer Test Isn’t Ready Yet

At ASCO 2026, Grail’s Galleri multi-cancer blood test showed promise but missed its main goal in the large NHS trial. Experts say it’s not ready for broad population screening yet.